Earnings History Data for Fusion Pharmaceuticals Inc. (FUSN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc. is a clinical-stage oncology company focused on developing radiopharmaceuticals as precision medicines. The compnay's lead program includes FPI-1434, which is in clinical trial. Fusion Pharmaceuticals Inc. is based in Hamilton, Canada.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20-03-2024 | AH | FUSN | Fusion Pharmaceuticals | 770.00 | -0.39 | -0.34 | 0.00 | Fusion Pharmaceuticals GAAP EPS of -$0.39 misses by $0.06 [3/20/2024 4:49 PM] |
21.18 | 0.09 (0.43%) |
21.10 | 0.01 (0.07%) |
2.31 - 21.21 | 3,735,385 | 6,340,000 | 5,017 | ||
| 07-11-2023 | PM | FUSN | Fusion Pharmaceuticals | 315.00 | -0.25 | -0.40 | 0.00 | Fusion Pharmaceuticals GAAP EPS of -$0.25 beats by $0.15, revenue of $2M beats by $1.91M [11/7/2023 8:27 AM] |
4.48 | 0.17 (3.91%) |
0.0 | 0.0 (0.00%) |
1.98 - 5.63 | 45,783 | 90,000 | 0 | ||
| 11-05-2023 | PM | FUSN | Fusion Pharmaceuticals | 263.00 | -0.45 | -0.29 | 0.00 | Fusion Pharmaceuticals GAAP EPS of -$0.45 misses by $0.23 [5/11/2023 11:56 AM] |
4.50 | 0.03 (0.67%) |
0.0 | 0.0 (0.00%) |
1.98 - 5.22 | 24,399 | 20,000 | 0 | ||
| 17-03-2022 | PM | FUSN | Fusion Pharmaceuticals | 303.00 | -0.40 | -0.47 | 0.00 | Fusion Pharmaceuticals GAAP EPS of -$0.40 beats by $0.09, revenue of $0.6M [3/17/2022 9:06 AM] |
7.67 | 0.45 (6.23%) |
0.0 | 0.0 (0.00%) |
4.09 - 12.47 | 3,725 | 50,803 | 0 | ||
| 11-05-2021 | PM | 7:30 AM ET (May 11) |
FUSN | Fusion Pharmaceuticals Inc. | 376.00 | -0.42 | -0.29 | 0.00 | Fusion Pharmaceuticals EPS misses by $0.14 [5/11/2021 8:25 AM] |
8.44 | -0.36 (-4.09%) |
0.0 | 0.0 (0.00%) |
8.09 - 19.00 | 29,360 | 20,000 | 0 | |
| 25-03-2021 | PM | FUSN | Fusion Pharmaceuticals Inc. | 499.00 | -0.32 | -0.19 | 0.00 | Fusion Pharmaceuticals EPS misses by $0.13 [3/25/2021 7:52 AM] |
10.50 | -0.50 (-4.55%) |
11.11 | 0.11 (1.00%) |
10.50 - 19.00 | 27,134 | 60,000 | 100 | ||
| 10-11-2020 | PM | FUSN | Fusion Pharmaceuticals Inc. | 569.96 | -0.24 | -0.22 | 0.00 | Fusion Pharmaceuticals EPS misses by $0.04 [11/10/2020 7:19 AM] |
12.44 | -0.03 (-0.24%) |
0.0 | 0.0 (0.00%) |
11.50 - 19.00 | 5,226 | 29,053 | 0 | ||
|
|
||||||||||||||||||